Pharming Group to participate in February investor conferences

Rhea-AI Summary

Pharming Group N.V. announces participation in investor conferences in February, including Oppenheimer 34th Annual Healthcare Life Sciences Virtual Conference and UBS European Healthcare Conference. CEO Sijmen de Vries to present at the Oppenheimer conference on February 13. Webcast and replay available on Pharming's website.

Leiden, The Netherlands, February 8, 2024: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) announces that Pharming’s management will participate in the following investor conferences in the month of February:

• Oppenheimer 34^th Annual Healthcare Life Sciences Virtual Conference, February 13-14, 2024
  Sijmen de Vries, Chief Executive Officer, will present on Tuesday, February 13 at 11:20 ET/17:20 CET. A live webcast and replay of the presentation will be available in the “Upcoming Events” and “News” sections of Pharming’s website.
• UBS European Healthcare Conference, London, U.K., February 28, 2024
  

For more information about these conferences, or to schedule a one-to-one meeting with Pharming’s management team, please contact Pharming’s Investor Relations team at investor@pharming.com or your Oppenheimer or UBS representative.

About Pharming Group N.V.

Pharming Group N.V. (Euronext Amsterdam: PHARM/Nasdaq: PHAR) is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. Pharming is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines, including small molecules, biologics, and gene therapies that are in early to late-stage development. Pharming is headquartered in Leiden, Netherlands, and has employees around the globe who serve patients in over 30 markets in North America, Europe, the Middle East, Africa, and Asia-Pacific.

For more information, visit www.pharming.com and find us on LinkedIn.

For further public information, contact:

Pharming Group, Leiden, The Netherlands
Michael Levitan, VP Investor Relations & Corporate Communications
T: +1 (908) 705 1696

Heather Robertson, Investor Relations & Corporate Communications Manager
E: investor@pharming.com

FTI Consulting, London, UK
Victoria Foster Mitchell/Alex Shaw/Amy Byrne
T: +44 203 727 1000

LifeSpring Life Sciences Communication, Amsterdam, The Netherlands
Leon Melens
T: +31 6 53 81 64 27
E: pharming@lifespring.nl

FAQ

When is Pharming Group N.V. participating in the Oppenheimer 34th Annual Healthcare Life Sciences Virtual Conference?

Pharming Group N.V. is participating in the Oppenheimer 34th Annual Healthcare Life Sciences Virtual Conference on February 13-14, 2024.

Who will present at the Oppenheimer conference?

CEO Sijmen de Vries will present at the Oppenheimer conference on Tuesday, February 13 at 11:20 ET/17:20 CET.

Where can the webcast and replay of the presentation be accessed?

The webcast and replay of the presentation will be available in the 'Upcoming Events' and 'News' sections of Pharming's website.